Dr. Norry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
351 Rouse Blvd
Philadelphia, PA 19112Phone+1 215-825-9260- Is this information wrong?
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Gastroenterology, 1993 - 1995
- Temple University HospitalResidency, Internal Medicine, 1989 - 1992
- New York University School of MedicineClass of 1989
Certifications & Licensure
- PA State Medical License 1991 - 2024
Publications & Presentations
PubMed
- 1 citationsAfamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.Sandra P D'Angelo, Dejka M Araujo, Albiruni R Abdul Razak, Mark Agulnik, Steven Attia, Jean-Yves Blay, Irene Carrasco Garcia, John A Charlson, Edwin Choy, George D Dem...> ;Lancet. 2024 Apr 13
- 1 citationsDurable control of metastases in an HLA-A2+ patient with refractory melanoma after low-dose radiotherapy in combination with MAGE-A4 T cell therapy: a case report.Kewen He, David S Hong, Danxia Ke, Partow Kebriaei, Tianjiao Wang, Hassan Danesi, Genevieve Bertolet, Carola Leuschner, Nahum Puebla-Osorio, Tiffany A Voss, Quan Lin, ...> ;Melanoma Research. 2023 Aug 1
- 29 citationsAutologous T cell therapy for MAGE-A4solid cancers in HLA-A*02patients: a phase 1 trial.David S Hong, Brian A Van Tine, Swethajit Biswas, Cheryl McAlpine, Melissa L Johnson, Anthony J Olszanski, Jeffrey M Clarke, Dejka Araujo, George R Blumenschein Jr, Pa...> ;Nature Medicine. 2023 Jan 1
- Join now to see all
Journal Articles
- Fludarabine and Neurotoxicity in Engineered T-cell TherapyElliot Norry, Crystal L Mackall, Nature
Press Mentions
- Data from Cohort 1 of SPEARHEAD-1 Trial at CTOS Continue to Support BLA Submission for Afami-Cel in Synovial Sarcoma - Response Rate and Durability Remain ConsistentNovember 18th, 2022
- Adaptimmune Reports Positive Results from Its Pivotal SPEARHEAD-1 Trial in Patients with Synovial Sarcoma and MRCLS at CTOSNovember 11th, 2021
- Adaptimmune to Present Data Updates at Upcoming CTOS and SITC MeetingsOctober 5th, 2021
- Join now to see all
Hospital Affiliations
- Jefferson Abington HealthAbington, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: